Rapid Lipid Modification of Endothelial Cell Membranes in Cardiac Ischemia/Reperfusion Injury: a Novel Therapeutic Strategy to Reduce Infarct Size

Ischemia Reperfusion ◽

Cardiac Ischemia ◽

Lipid Modification ◽

Reduce Infarct Size ◽

Targeting autophagy in cardiac ischemia/reperfusion injury: A novel therapeutic strategy

Journal of Cellular Physiology ◽

10.1002/jcp.28345 ◽

2019 ◽

Vol 234 (10) ◽

pp. 16768-16778 ◽

Cited By ~ 16

Author(s):

Mehrdad Aghaei ◽

Morteza Motallebnezhad ◽

Sajjad Ghorghanlu ◽

Ali Jabbari ◽

Ayesheh Enayati ◽

...

Keyword(s):

Reperfusion Injury ◽

Therapeutic Strategy ◽

Ischemia Reperfusion ◽

Cardiac Ischemia ◽

Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury

BMC Pharmacology and Toxicology ◽

10.1186/s40360-020-0400-0 ◽

2020 ◽

Vol 21 (1) ◽

Cited By ~ 1

Author(s):

Chao-Feng Lin ◽

Kai-Cheng Hsu ◽

Wei-Chun HuangFu ◽

Tony Eight Lin ◽

Han-Li Huang ◽

...

Keyword(s):

Infarct Size ◽

Reperfusion Injury ◽

Histone Deacetylase ◽

Ischemia Reperfusion ◽

Cardiac Ischemia ◽

Histone Deacetylase 6

Effects of Sulfaphenazole Derivatives on Cardiac Ischemia–Reperfusion Injury: Association of Cytochrome P450 Activity and Infarct Size

Journal of Pharmacological Sciences ◽

10.1254/jphs.10103fp ◽

2010 ◽

Vol 113 (4) ◽

pp. 335-342 ◽

Cited By ~ 9

Author(s):

Yasuhiro Ishihara ◽

Masaya Sekine ◽

Ai Hamaguchi ◽

Yusuke Kobayashi ◽

Takashi Harayama ◽

...

Keyword(s):

Cytochrome P450 ◽

Infarct Size ◽

Reperfusion Injury ◽

Ischemia Reperfusion ◽

Cardiac Ischemia ◽

Cytochrome P450 Activity ◽

P450 Activity

P515Phosphorylcholine antibodies preserve cardiac function and reduce infarct size by attenuation of the inflammatory response following myocardial ischemia-reperfusion injury

Cardiovascular Research ◽

10.1093/cvr/cvy060.372 ◽

2018 ◽

Vol 114 (suppl_1) ◽

pp. S125-S126

Author(s):

N J Pluijmert ◽

RCM De Jong ◽

M R De Vries ◽

K Pettersson ◽

J W Jukema ◽

...

Keyword(s):

Myocardial Ischemia ◽

Inflammatory Response ◽

Cardiac Function ◽

Infarct Size ◽

Reperfusion Injury ◽

Ischemia Reperfusion ◽

Reduce Infarct Size ◽

Myocardial Ischemia Reperfusion Injury ◽

Myocardial Ischemia Reperfusion

Surgical Research Society of Australasia - Diannexin Reduces Tissue Factor Positive Microparticles, Microvascular Obstruction and Endothelial Cell and Myocyte Necrosis, in Cardiac Ischemia Reperfusion Injury

Journal of Surgical Research ◽

10.1016/j.jss.2011.11.450 ◽

2012 ◽

Vol 172 (2) ◽

pp. 272

Author(s):

Connor O'Meara

Keyword(s):

Endothelial Cell ◽

Reperfusion Injury ◽

Tissue Factor ◽

Microvascular Obstruction ◽

Ischemia Reperfusion ◽

Research Society ◽

Cardiac Ischemia ◽

Surgical Research

Proteasome inhibitors: possible novel therapeutic strategy for ischemia–reperfusion injury?

Expert Opinion on Investigational Drugs ◽

10.1517/13543784.2013.840287 ◽

2013 ◽

Vol 23 (1) ◽

pp. 67-80 ◽

Cited By ~ 4

Author(s):

Apostolos N Kandilis ◽

Nikolaos P Karidis ◽

Gregory Kouraklis ◽

Efstratios Patsouris ◽

Ioanna Vasileiou ◽

...

Keyword(s):

Reperfusion Injury ◽

Therapeutic Strategy ◽

Ischemia Reperfusion ◽

Proteasome Inhibitors ◽

Faculty Opinions recommendation of Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1008695.372854 ◽

2006 ◽

Author(s):

Andreas Deussen

Keyword(s):

Infarct Size ◽

Reperfusion Injury ◽

Myocardial Infarct ◽

Ischemia Reperfusion ◽

Phosphodiesterase Inhibitor ◽

Myocardial Infarct Size

SIRT1 as a Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury and Cardiometabolic Disease

Current Drug Targets ◽

10.2174/1389450116666150630110529 ◽

2017 ◽

Vol 18 (15) ◽

Cited By ~ 7

Author(s):

Dong Han ◽

Jinda Wang ◽

Sai Ma ◽

Yundai Chen ◽

Feng Cao

Keyword(s):

Myocardial Ischemia ◽

Reperfusion Injury ◽

Therapeutic Target ◽

Ischemia Reperfusion ◽

Cardiometabolic Disease ◽

Myocardial Ischemia Reperfusion Injury ◽

Myocardial Ischemia Reperfusion ◽

406-1 Hypoxia regulatable Aav-2 vector protects against cardiac ischemia/reperfusion injury

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(04)92260-7 ◽

2004 ◽

Vol 43 (5) ◽

pp. A533

Author(s):

Alok S Pachori ◽

Luis G Melo ◽

Lunan Zhang ◽

Richard E Pratt ◽

Victor J Dzau

Keyword(s):

Reperfusion Injury ◽

Ischemia Reperfusion ◽

Cardiac Ischemia

INHIBITION OF APOPTOSIS AND FERROPTOSIS EXERTS HIGHER EFFICACY IN REDUCING CARDIAC ISCHEMIA/REPERFUSION INJURY THAN NECROPTOSIS INHIBITOR IN RATS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(21)01489-3 ◽

2021 ◽

Vol 77 (18) ◽

pp. 130

Author(s):

Ying Luo ◽

Suchan Liao ◽

Jun Wu ◽

Busarin Arunsak ◽

Thidarat Jaiwongkam ◽

...

Keyword(s):

Reperfusion Injury ◽

Ischemia Reperfusion ◽

Cardiac Ischemia